Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood

Marijke J. E. Kuijpers; Cécile M. A. Nieuwenhuys; Marion A. H. Feijge; Willem Kloots; Peter L. A. Giesen; Johann C. Jerling; Mirjam G. A. oude Egbrink; Johan W. M. Heemskerk

doi:10.1160/TH04-02-0091

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2005; 93(01): 97-105
DOI: 10.1160/TH04-02-0091

Platelets and Blood Cells

Schattauer GmbH

Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood

Autor*innen

Marijke J. E. Kuijpers

¹The Departments of Biochemistry, Unilever Research Vlaardingen, Vlaardingen, The Netherlands
Cécile M. A. Nieuwenhuys

²Human Biology, Unilever Research Vlaardingen, Vlaardingen, The Netherlands
Marion A. H. Feijge

¹The Departments of Biochemistry, Unilever Research Vlaardingen, Vlaardingen, The Netherlands
Willem Kloots

³Unilever Health Institute, Unilever Research Vlaardingen, Vlaardingen, The Netherlands
Peter L. A. Giesen

⁴Synapse, Unilever Research Vlaardingen, Vlaardingen, The Netherlands
Johann C. Jerling

³Unilever Health Institute, Unilever Research Vlaardingen, Vlaardingen, The Netherlands

^*Present address: Potchefstroom Institute of Nutrition, School of Physiology, Nutrition and Consumer Science, Potchefstroom University for Christian Higher Education, South Africa.
Mirjam G. A. oude Egbrink

⁵Physiology CARIM, University of Maastricht, Maastricht, The Netherlands
Johan W. M. Heemskerk

¹The Departments of Biochemistry, Unilever Research Vlaardingen, Vlaardingen, The Netherlands

²Human Biology, Unilever Research Vlaardingen, Vlaardingen, The Netherlands

Abstract

Volltext

als PDF herunterladen

Keywords

Coagulation - platelets - prostaglandin - thrombin - thrombus

Referenzen

References
1 Giesen PL, Rauch U, Bohrmann B. et al Bloodborne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-15.
2 Plow EF, Cierniewski CS, Xiao Z. et al α IIbβ 3 and its antagonism at the new millennium. Thromb Haemost 2001; 86: 34-40.
3 Walsh PN. Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. Thromb Haemost 2001; 86: 75-82.
4 Smeets EF, Heemskerk JWM, Comfurius P. et al Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb Haemost 1993; 70: 1024-9.
5 Heemskerk JWM, Vuist WMJ, Feijge MAH. et al Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets. Blood 1997; 90: 2615-25.
6 Bevers EM, Comfurius P, van Rijn JL. et al Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122: 429-36.
7 Swords NA, Mann KG. The assembly of the prothrombinase complex on adherent platelets. Arterioscler Thromb 1993; 13: 1602-12.
8 Zwaal RFA, Schroit AJ. Pathophysiological implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
9 Briedé JJ, Heemskerk JWM, van 't Veer C. et al Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogenadherent platelets. Thromb Haemost 2001; 85: 509-13.
10 Rosing J, Bevers EM, Comfurius P. et al Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 1985; 65: 1557-61.
11 Weiss HJ. Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol 1994; 31: 312-9.
12 Reverter JC, Béguin S, Kessels H. et al Inhibition of platelet-mediated, tissue-factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'. J Clin Invest 1996; 98: 863-74.
13 Béguin S, Kumar R. Thrombin, fibrin and platelets: a resonance loop in which von Willebrand factor is a necessary link. Thromb Haemost 1997; 78: 590-4.
14 Keularts IML, Béguin S, de Zwaan C. et al Treatment with a GPIIb-IIIa antagonist inhibits thrombin generation in platelet-rich plasma from patients. Thromb Haemost 1998; 80: 370-1.
15 Béguin S, Kumar R, Keularts I. et al Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor. Blood 1999; 93: 564-70.
16 Vanschoonbeek K, Feijge MAH, Van Kampen RJ. et al Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma. J Thromb Haemost 2004; 2: 476-84.
17 Léon C, Ravanat C, Freund M. et al Differential involvement of the P2Y1 and P2Y12 receptor in platelet procoagulant activity. Arterioscler Thromb Vasc Biol 2003; 23: 1941-7.
18 Daniel JL, Dangelmaier C, Jin J. et al Molecular basis for ADP-induced platelet activation. I: evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998; 273: 2024-9.
19 Hechler B, Eckly A, Ohlmann P. et al The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 1998; 103: 858-66.
20 Hérault JP, Dol F, Gaich C. et al Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thromb Haemost 1999; 81: 957-60.
21 Ingall AH, Dixon J, Bailey A. et al Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem 1999; 42: 213-20.
22 Hollopeter G, Jantzen HM, Vincent D. et al Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409: 202-8.
23 Matsuno H, Uematsu T, Nagashima S. et al Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Meth 1991; 25: 303-17.
24 Inamo J, Belougne E, Doutremepuich C. Importance of photo activation of rose bengal for platelet activation in experimental models of photochemically induced thrombosis. Thromb Res 1996; 83: 229-35.
25 Nieuwenhuys CMA, Béguin S, Offermans RF. et al Hypocoagulant and lipid-lowering effects of dietary n-3 polyunsaturated fatty acids with unchanged platelet activation in rats. Arterioscler Thromb Vasc Biol 1998; 18: 1480-9.
26 Nieuwenhuys CMA, Feijge MAH, Béguin S. et al Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma. Thromb Haemost 2000; 84: 1045-51.
27 Jerling JC, Curiel-Martos A, Kroner C. et al Fish oil inhibits photochemically induced thrombosis in the guinea pig in a dose dependent manner. Thromb Res 2003; 111: 11-17.
28 Nieuwenhuys CMA, Hornstra G. The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats. Biochim Biophys Acta 1998; 1390: 313-22.
29 Hemker HC, Giesen PLA, Ramjee M. et al The thrombogram: monitoring thrombin generation in platelet rich plasma. Thromb Haemost 2000; 83: 589-91.
30 Heemskerk JWM, Willems GM, Rook MB. et al Ragged spiking of free calcium in ADP-stimulated human platelets: regulation of puff-like calcium signals in vitro and ex vivo. J Physiol 2001; 535: 625-35.
31 Fungaloi P, Waterman P, Nigri G. et al Photochemically modulated endothelial cell thrombogenicity via the thrombomodulin-tissue factor pathways. Photochem Photobiol 2003; 78: 475-80.
32 Heemskerk JWM, Feijge MAH, Sage SO. et al Indirect regulation of Ca2+ entry by cAMP-dependent and cGMP-dependent protein kinases and phospholipase C in rat platelets. Eur J Biochem 1994; 223: 543-51.
33 Keularts IML, van Gorp RM, Feijge MAH. et al α 2A-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J Biol Chem 2000; 275: 1763-72.
34 Van Willigen G, Akkerman JWN. Regulation of glycoprotein IIb/IIIa exposure on platelets stimulated with alpha-thrombin. Blood 1992; 79: 82-90.
35 Pasquet JM, Dachary-Prigent J, Nurden AT. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996; 239: 647-54.
36 Butenas S, Cawthern KM, van 't Veer C. et al Antiplatelet agents in tissue factor-induced blood coagulation. Blood 2001; 97: 2314-22.
37 Gianetti J, De Caterina M, De Cristofaro T. et al Intravenous prostaglandin E 1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. Am Heart J 2001; 142: 733-9.
38 Weiss T, Fischer D, Hausmann D. et al Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E 1 . Prostaglandins Leukotr Essent Fatty Acids 2002; 67: 277-81.
39 Makino H, Aoki M, Hashiya N. et al Increase in peripheral blood flow by intravenous administration of prostaglandin E 1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor. Hypertens Res 2004; 27: 85-91.